ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc (RANI)

2.58
-0.04
( -1.53% )
更新日時: 03:19:04

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
2.58
買値
2.57
売値
2.59
出来高
243,666
2.55 日の範囲 2.67
1.90 52 週間の範囲 8.75
時価総額
前日終値
2.62
始値
2.62
最終取引時間
03:22:54
財務取引量
US$ 636,948
VWAP
2.614
平均取引量 (3 か月)
1,758,705
発行済株式数
53,406,508
配当利回り
-
PER
-4.06
1 株当たり利益 (EPS)
-0.64
歳入
-
純利益
-33.97M

Rani Therapeutics Holdings Inc について

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker RANI. The last closing price for Rani Therapeutics was US$2.62. Over the last year, Rani Therapeutics shares have traded in a share price range of US$ 1.90 to US$ 8.75.

Rani Therapeutics currently has 53,406,508 shares in issue. The market capitalisation of Rani Therapeutics is US$139.93 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -4.06.

RANI 最新ニュース

Rani Therapeutics to Participate in Upcoming Investor Conferences

SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

-Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous...

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

SAN JOSE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

SAN JOSE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) --  Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics to Participate in September Investor Conferences

SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

- Announced partnership with ProGen on development of RT-114, an oral GLP-1/GLP-2 dual agonist for the treatment of obesity - - Phase 1 study for RT-114 expected to initiate in 2025...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.145.737704918032.442.672.325673502.49382929CS
4-1.02-28.33333333333.63.752.123129572.34420556CS
12-0.35-11.94539249152.933.75217587052.79253884CS
26-3.78-59.43396226426.366.928550532.84036253CS
520.6332.30769230771.958.751.94937863.06342301CS
156-25.64-90.857547838428.2236.271.821981594.18424296CS
260-8.68-77.087033747811.2636.271.822028935.85430364CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BTCTBTC Digital Ltd
US$ 11.175
(343.45%)
104.06M
MULNMullen Automotive Inc
US$ 2.7898
(63.15%)
36.58M
PAMTPAMT Corporation
 20.01
(58.68%)
42.14k
LGMKLogicMark Inc
US$ 0.21
(57.89%)
505.02M
GNPXGenprex Inc
US$ 2.0392
(52.18%)
19.07M
NGNENeurogene Inc
US$ 36.65
(-48.76%)
896.42k
STIMNeuronetics Inc
US$ 0.66
(-40.00%)
5.83M
RMTIRockwell Medical Inc
US$ 2.865
(-38.39%)
4.74M
PGYPagaya Technologies Ltd
US$ 10.412
(-38.35%)
9.6M
RAILFreightCar America Inc
US$ 9.9101
(-36.92%)
1.85M
CEROCERo Therapeutics Holdings Inc
US$ 0.255
(30.10%)
636.36M
LGMKLogicMark Inc
US$ 0.2096
(57.59%)
505.15M
LIFWMSP Recovery Inc
US$ 0.12185
(-3.83%)
161.4M
NVDANVIDIA Corporation
US$ 147.535
(1.57%)
127.99M
ELABElevai Labs Inc
US$ 0.018699
(-3.11%)
111.85M

RANI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock